| Product Name | MF | CAS | Details |
|---|
| Clopidogrel EP Impurity A | C15H14ClNO2S | 144457-28-3 | Details |
| Troxagliptin impuritiesX | C18H22FN5O3 | 1938080-44-4 | Details |
| Clopidogrel Impurities8 | C17H18ClNO2S | 782477-51-4 | Details |
| LCZ696 impurities506-07 | C22H23NO4 | 2216746-87-9 | Details |
| (S)-Clopidogrel N-Oxide | C16H16ClNO3S | 1319197-71-1 | Details |
| alogliptin impurities7 | C25H25N5O3 | 1618644-32-8 | Details |
| Afatinib Impurity11 | C18H16F2N4O2 | 2044709-72-8 | Details |
| Dabigatran Impurity 21 | C41H55N7O8 | 1643392-59-9 | Details |
| Dabigatran etexilate impurity6 | C25H26N8O2 | 1643377-48-3 | Details |
| LCZ696 impuritiesA | C24H29NO5 | 761373-05-1 | Details |
| Olmesartan Medoxomil Impurity10 | C10H16N2O3 | 144690-04-0 | Details |
| Azilsartan medoxomil impurityC | C24H22N4O4 | 1397836-49-5 | Details |
| Erlotinib Impurity M | C23H25N3O4 | 1346601-52-2 | Details |
| alogliptin impurities4 | C25H24N6O2 | 865759-10-0 | Details |
| Gefitinib Impurity 5 | C15H23N3O4 | 246512-44-7 | Details |
| alogliptin impurities1 | C8H9ClN2 | 1134529-25-1 | Details |
| Azilsartan medoxomil Impurity H | C23H20N4O4 | 1499167-72-4 | Details |
| Afatinib Impurity10 | C19H16ClFN4O3 | 2223677-60-7 | Details |
| Linezolid Impurity11 | C13H18ClFN2O2 | 868405-66-7 | Details |
| Cetirizine EP Impurity C | C21H25ClN2O3 | 83881-59-8 | Details |
| Gefitinib Impurity 6 | C22H23ClFN3O4 | 1608115-59-8 | Details |
| LCZ697 impuritiesB | C24H29NO5 | 766480-48-2 | Details |
| Afatinib Impurity6 | C15H10ClFN4O3 | 179552-74-0 | Details |
| Dabigatran etexilate impurity14 | C27H29N7O3 | 429658-95-7 | Details |
| Sorafenib impurities14 | C21H17F3N4O4 | 862875-16-9 | Details |
| Azilsartan medoxomil impurity5 | C29H25N3O7 | 1696392-12-7 | Details |
| Linezolid Impurity 21 | C16H20FN3O6 | 368891-70-7 | Details |
| Gefitinib Impurity14 | C20H22ClFN4O3 | 847949-56-8 | Details |
| LCZ696 impurities1 | C26H33NO5 | 2376611-98-0 | Details |
| Troxagliptin impuritiesY | C13H10FN3O3 | 1938080-42-2 | Details |
| Clopidogrel Impurities4 | C10H12ClNO2 | 1195954-07-4 | Details |
| Olmesartan Medoxomil Impurity14 | C43H38N6O2 | 1048948-15-7 | Details |
| Linezolid Impurity14 | C22H20FN3O5 | 168828-89-5 | Details |
| Erlotinib Impurity D | C20H23N3O4 | 1145671-52-8 | Details |
| Oxcarbazepine EP Impurity H | C15H13NO | 4698-11-7 | Details |
| Cetirizine Impurity2 | C21H25ClN2O3 | 1232460-31-9 | Details |
| Olmesartan Medoxomil EP Impurity C | C29H28N6O5 | 879562-26-2 | Details |
| Cetirizine EP ImpurityD | C30H28Cl2N2 | 346451-15-8 | Details |
| Erlotinib Impurity7 | C21H21Cl2N3O3 | 183320-04-9 | Details |
| Linezolid Impurity4 | C15H19FN2O6S | 2180621-71-8 | Details |
| Dabigatran etexilate impurity4 | C34H41N7O5 | 2225986-95-6 | Details |
| Olmesartan Medoxomil Impurity19 | C24H26N6O3 | 144689-24-7 | Details |
| Azilsartan medoxomil Impurity J | C24H18N4O5 | 1403474-78-1 | Details |
| Levocetirizine Impurity 5 | C23H23ClN2O2S | 1391052-52-0 | Details |
| Linezolid dimer | C30H35F2N5O7 | 908143-04-4 | Details |
| Sorafenib impurities7 | C16H17N3O4 | 2206827-12-3 | Details |
| Troxagliptin impurities1 | C40H42F2N10O6 | 2087874-94-8 | Details |
| Azilsartan medoxomil Impurity B | C24H21N3O4 | 1696392-11-6 | Details |
| Clopidogrel Impurities1 | C18H20ClNO4S | 1346231-36-4 | Details |
| Linezolid Related Compound A | C14H16FN5O3 | 168828-84-0 | Details |
| alogliptin impurities8 | C25H27N5O4 | 1638544-64-5 | Details |
| Linezolid Impurity2 | C15H20FN3O2 | 2512211-93-5 | Details |
| Cetirizine Impurity1 | C19H25Cl3N2O | 164726-80-1 | Details |
| Erlotinib Impurity E | C23H23N3O5 | 183320-15-2 | Details |
| Azilsartan medoxomil impurity1 | C26H22N4O5 | 147403-52-9 | Details |
| (R)-Cetirizine EP Impurity A | C17H19ClN2 | 300543-56-0 | Details |
| Erlotinib Impurity4 | C21H22ClN3O4 | 183365-34-6 | Details |
| Linezolid ImpurityC | C14H18FN3O3 | 168828-90-8 | Details |
| Olmesartan Medoxomil Impurity7 | C45H44N6O3 | 144690-33-5 | Details |
| Dabigatran Impurity 22 | C27H29N7O4 | 658078-29-6 | Details |
| Cetirizine EP Impurity F | C21H26N2O3 | 83881-53-2 | Details |
| Cetirizine EP Impurity B DiHCl | C19H22Cl2N2O2 | 1000690-91-4 | Details |
| Oxcarbazepine EP Impurity F | C16H12ClNO2 | 28721-08-6 | Details |
| Clopidogrel EP Impurity E(S) | C15H15ClN2OS | 444728-13-6 | Details |
| Olmesartan Medoxomil Impurity13 | C25H28N6O3 | 1347262-29-6 | Details |
| Linezolid Impurity3 | C22H21N3O5 | 556801-12-8 | Details |
| Dabigatran Impurity U | C19H21N5O2 | 1408238-41-4 | Details |
| Azilsartan medoxomil impurity3 | C9H6N4O5 | 856414-36-3 | Details |
| Gefitinib Impurity15 | C16H21N3O4 | 199327-61-2 | Details |
| alogliptin impurities6 | C17H19N5O2 | 865758-98-1 | Details |
| Afatinib Impurity2 | C7H14N2O | 2348580-72-1 | Details |
| Cetirizine Amide Dihydrochloride | C21H28Cl3N3O2 | 200707-85-3 | Details |
| Oxcarbazepine Impurity 4 | C15H11BrClNO | 33948-20-8 | Details |
| Dabigatran Impurity 19 | C34H41N7O5 | 2225986-94-5 | Details |
| Gefitinib Impurity I | C29H37ClFN5O4 | 1502829-45-9 | Details |
| Olmesartan Medoxomil EP Impurity B | C24H24N6O2 | 849206-43-5 | Details |
| LCZ696 impurities575-11 | C18H22ClNO2 | 1038924-71-8 | Details |
| Dabigatran Impurity 23 | C36H45N7O5 | 211915-07-0 | Details |
| Linezolid Hydrochloride Impurity D | C15H23ClFN3O3 | 1391068-25-9 | Details |
| Erlotinib Impurity1 | C13H20N2O5 | 236750-62-2 | Details |
| Dabigatran Methyl Ester Impurity | C26H27N7O3 | 771459-37-1 | Details |
| Afatinib Impurity5 | C7H13NO2 | 1259015-90-1 | Details |
| Linezolid Impurity15 | C32H31FN4O7 | 1798014-14-8 | Details |
| LCZ696 impuritiesC | C24H29NO5 | 149709-63-7 | Details |
| Olmesartan Medoxomil Impurity8 | C12H20N2O3 | 144689-93-0 | Details |
| Linezolid N-Oxide | C16H20FN3O5 | 189038-36-6 | Details |
| Dabigatran etexilate impurity11 | C32H36N6O6 | 1408238-37-8 | Details |
| LCZ696 impurities3 | C23H29NO4 | 1012341-56-8 | Details |
| Desethyl Dabigatran Etexilate | C32H37N7O5 | 212321-78-3 | Details |
| Olmesartan Medoxomil Impurity11 | C44H40N6O3 | 2101308-73-8 | Details |
| Troxagliptin impurities4 | 20787874-91-5 | Details |
| Sorafenib impurities10 | C20H13ClF3N3O4 | 1012058-78-4 | Details |
| Oxcarbazepine EP Impurity D | C14H9NO2 | 19579-83-0 | Details |
| Afatinib Impurity7 | C14H8ClFN4O3 | 2475094-95-0 | Details |
| Clopidogrel EP Impurity B HCl | C16H17Cl2NO2S | 1396607-35-4 | Details |
| Afatinib Impurity1 | C22H20ClFN4O4 | 2223677-58-3 | Details |
| Erlotinib Impurity A | C12H11Cl3N2O2 | 183322-21-6 | Details |
| LCZ696 impuritiesE | C23H29NO4 | 1012341-52-4 | Details |
| Clopidogrel EP Impurity E | C15H15ClN2OS | 90055-68-8 | Details |
| Dabigatran etexilate impurity10 | C26H33N5O4 | 1408238-36-7 | Details |
| Product Total： Product Page： | ||||
| 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 | ||||